SCHEMBL17657691

SCHEMBL17657691

Cc1cc(C)c2ccc(C=O)cc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.58
CYP1A2 P05177 2/20 0.53
ALDH1A1 P00352 7/20 0.39
CYP2A6 P11509 2/20 0.39
KDM4E B2RXH2 6/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 4/20 0.39
MEN1 O00255 3/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HPGD P15428 2/20 0.39
NPC1 O15118 1/20 0.39
PTK2B Q14289 1/20 0.39
NR4A2 P43354 1/20 0.39
DHFR P00374 1/20 0.38
ALDH1A3 P47895 2/20 0.38
MPI P34949 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28910025 0.85 CYP1A2 (0.53) POLBCYP1A2ALDH1A1CYP2A6KDM4E
SCHEMBL5517317 0.84 MAPT (0.51) POLBCYP1A2ALDH1A1CYP2A6KDM4E
SCHEMBL30908463 0.82 KDM4E (0.46) POLBCYP1A2ALDH1A1CYP2A6KDM4E
SCHEMBL9828211 0.80 LMNA (0.47) POLBCYP1A2ALDH1A1CYP2A6KMT2A
SCHEMBL17657687 0.77 CYP1A2 (0.55) POLBCYP1A2CYP2A6KDM4E
SCHEMBL7003951 0.76 CCR1 (0.44) POLBCYP1A2ALDH1A1CYP2A6KDM4E
SCHEMBL874427 0.76 POLB (0.66) POLBCYP1A2ALDH1A1KDM4EKMT2A
SCHEMBL17646471 0.75 KDM4E (0.41) KDM4EMAPTL3MBTL1
SCHEMBL24976102 0.74 LMNA (0.62) POLBCYP1A2ALDH1A1KDM4EKMT2A
SCHEMBL28910028 0.74 IDO1 (0.44) POLBCYP1A2ALDH1A1CYP2A6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9783500-B2 2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition NORTHWESTERN UNIVERSITY (US) 2017-10-10 US disclosed
US-9663468-B2 2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition NORTHWESTERN UNIVERSITY (US) 2017-05-30 US disclosed
US-20160368877-A1 2-Aminoquinoline-Based Compounds for Potent and Selective Neuronal Nitric Oxide Synthase Inhibition NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-12-22 US disclosed
US-20160096806-A1 2-Aminoquinoline-Based Compounds for Potent and Selective Neuronal Nitric Oxide Synthase Inhibition NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368877-A1 2-Aminoquinoline-Based Compounds for Potent and Selective Neuronal Nitric Oxide Synthase Inhibition NOS2, NOS3, NOS1 POLB 2405/4885CYP1A2 371/4885ALDH1A1 823/4885
US-20160096806-A1 2-Aminoquinoline-Based Compounds for Potent and Selective Neuronal Nitric Oxide Synthase Inhibition NOS2, NOS3, NOS1 POLB 2405/4885CYP1A2 371/4885ALDH1A1 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.